Biological differences between two commercial anti-CD19 CAR T cells products and impact on outcomes in lymphoma patients. - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Access content directly
Conference Poster Year : 2022

Biological differences between two commercial anti-CD19 CAR T cells products and impact on outcomes in lymphoma patients.

Philippe Moreau
Fichier principal
Vignette du fichier
Poster ASH 2022 CLEMENCEAU.pdf (981.99 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-03956740 , version 1 (25-01-2023)

Identifiers

  • HAL Id : inserm-03956740 , version 1

Cite

Benoit Tessoulin, Audrey Grain, Jocelyn Ollier, Thomas Gastinne, Viviane Dubruille, et al.. Biological differences between two commercial anti-CD19 CAR T cells products and impact on outcomes in lymphoma patients.. The 64th American Society of Hematology Annual Meeting and Exposition ASH 2022, Dec 2022, New Orleans, Louisiana, United States. ⟨inserm-03956740⟩
14 View
13 Download

Share

Gmail Facebook X LinkedIn More